Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

5.29
+0.13002.52%
Post-market: 5.290.00000.00%16:05 EDT
Volume:762.28K
Turnover:3.98M
Market Cap:361.48M
PE:-2.40
High:5.32
Open:5.13
Low:5.06
Close:5.16
Loading ...
Mar 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Correspondence

Form CORRESP - Correspondence
Jan 13, 2025

Correspondence

Form CORRESP - Correspondence
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities